Cytokine expression in primary cutaneous germinal center cell lymphomas

被引:11
作者
Asadullah, K
Gellrich, S
Haeussler-Quade, A
Friedrich, M
Döcke, WD
Jahn, S
Sterry, W
机构
[1] Humboldt Univ, Med Sch Charite, Dept Dermatol, D-10098 Berlin, Germany
[2] Humboldt Univ, Med Sch Charite, Dept Med Immunol, D-10098 Berlin, Germany
关键词
B-cells; cytokines; CBCL; CTCL; lymphoma; TNF; interleukin;
D O I
10.1034/j.1600-0625.2000.009001071.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Physiologically, B-lymphocytes are not present in the skin. Even in pathological situations they rarely occur. In contrast, primary cutaneous B-cell lymphomas (CBCL) are characterized by proliferation of B lymphocytes within the skin. This suggests the existence of a certain microenvironment supporting homing and expansion of clonal B cells. Cytokines were demonstrated to be involved in the pathogenesis of cutaneous lymphomas of T-cell origin. Cytokine expression in cutaneous B-cell lymphoma lesions, however, has not been investigated so far. Therefore, the mRNA level of several cytokines was analyzed in biopsies from 7 patients with CBCL and compared to pleomorphic T-cell lymphoma (n=6), psoriasis (n=9), and healthy skin (n=7), using a competitive RT-PCR approach. An overexpression of TNF-alpha, IL-10, and IL-6 was found. Enhanced IL-8 mRNA expression was detected in 2/7 cases. The overexpression of IL-6 and IL-10 in CBCL might be of particular importance, since these cytokines are considered to support B-cell growth. Additionally, the overexpression of IL-10 may contribute to tumor progression since this immunosuppressive cytokine might be involved in downregulation of immunological tumor surveillance, in part by inhibiting type 1 cytokine formation. In fact, we did not detect IFN-gamma and IL-2 expression. Taken together, we found a cytokine pattern in CBCL lesions which might contribute to tumor B-cell growth.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 43 条
[11]   Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (Interferon-gamma receptor beta-chain) [J].
Dummer, R ;
Heald, PW ;
Nestle, FO ;
Ludwig, E ;
Laine, E ;
Hemmi, S ;
Burg, G .
BLOOD, 1996, 88 (04) :1383-1389
[12]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[13]  
FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
[14]  
FORD RJ, 1990, BLOOD, V75, P1311
[15]  
Friedrich M, 1998, J INVEST DERMATOL, V110, P586
[16]   INTERLEUKIN-10 PRODUCTION BY HUMAN CARCINOMA CELL-LINES AND ITS RELATIONSHIP TO INTERLEUKIN-6 EXPRESSION [J].
GASTL, GA ;
ABRAMS, JS ;
NANUS, DM ;
OOSTERKAMP, R ;
SILVER, J ;
LIU, F ;
CHEN, M ;
ALBINO, AP ;
BANDER, NH .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (01) :96-101
[17]   Molecular analysis of the immunoglobulin V-H gene rearrangement in a primary cutaneous immunoblastic B-cell lymphoma by micromanipulation and single-cell PCR [J].
Gellrich, S ;
Golembowski, S ;
Audring, H ;
Jahn, S ;
Sterry, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (04) :541-545
[18]   UPPER KERATINOCYTES OF PSORIATIC SKIN-LESIONS EXPRESS HIGH-LEVELS OF NAP-1/IL-8 MESSENGER-RNA INSITU [J].
GILLITZER, R ;
BERGER, R ;
MIELKE, V ;
MULLER, C ;
WOLFF, K ;
STINGL, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (01) :73-79
[19]  
Greiner A, 1997, AM J PATHOL, V150, P1583
[20]   TUMOR-NECROSIS-FACTOR LIGAND SUPERFAMILY - INVOLVEMENT IN THE PATHOLOGY OF MALIGNANT-LYMPHOMAS [J].
GRUSS, HJ ;
DOWER, SK .
BLOOD, 1995, 85 (12) :3378-3404